UniProtKB/Swiss-Prot P54098: Variant p.Arg1146Cys

DNA polymerase subunit gamma-1
Gene: POLG
Feedback?

Variant information Variant position:

1146 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant:

US The variants are classified into three categories: LP/P, LB/B and US.

LP/P: likely pathogenic or pathogenic.
LB/B: likely benign or benign.
US: uncertain significance

Residue change:

From Arginine (R) to Cysteine (C) at position 1146 (R1146C, p.Arg1146Cys). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties:

Change from large size and basic (R) to medium size and polar (C) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score:

-3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:

Lowest score: -4 (low probability of substitution).
Highest score: 11 (high probability of substitution).

More information can be found on the following page
Variant description:

In PEOB1; uncertain significance. Any additional useful information about the variant.
Other resources:

Links to websites of interest for the variant.

Variant rs2307440 [ dbSNP | Ensembl ]

Sequence information Variant position:

1146 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length:

1239 The length of the canonical sequence.
Location on the sequence:

DGRFCISIHDEVRYLVREED R YRAALALQITNLLTRCMFAY The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation:

The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         DGRFCISIHDEVRYLVREEDRYRAALALQITNLLTRCMFAY

Mouse                         DGRFCISIHDEVRYLVREEDRYRAALALQITNLLTRCMFAY

Rat                           DGRFCISIHDEVRYLVREEDRYRAALALQITNLLTRCMFAY

Xenopus laevis                DGRFCISIHDEVRYLVHSKDRYRAALALQITNLLTRCMFAS

Drosophila                    --RFCLSFHDELRYLVKEELSPKAALAMHITNLMTRSFCVS

Sequence annotation in neighborhood:

The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:

Type: the type of sequence feature.
Positions: endpoints of the sequence feature.
Description: contains additional information about the feature.

Type	Positions	Description
Chain	1 – 1239	DNA polymerase subunit gamma-1
Binding site	1135 – 1135
Binding site	1135 – 1135
Binding site	1135 – 1135
Mutagenesis	1135 – 1135	D -> N. Abolishes DNA polymerase activity.
Helix	1146 – 1166

Literature citations
Submission
NIEHS SNPs program;
Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]; VARIANTS GLN-55 INS; GLN-193; CYS-546; LYS-662; TRP-1142; GLY-1143; CYS-1146 AND HIS-1236; Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population.
Gonzalez-Vioque E.; Blazquez A.; Fernandez-Moreira D.; Bornstein B.; Bautista J.; Arpa J.; Navarro C.; Campos Y.; Fernandez-Moreno M.A.; Garesse R.; Arenas J.; Martin M.A.;
Arch. Neurol. 63:107-111(2006)
Cited for: VARIANTS PEOB1 LEU-603; TRP-853; CYS-1146 AND ASN-1184;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.